{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:32:35Z","timestamp":1789605155318,"version":"build-2803163510"},"reference-count":15,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychol."],"abstract":"<jats:p><jats:bold>Aim:<\/jats:bold> To evaluate health-related quality of life (HRQoL) of chronic hepatitis B (CHB) and hepatitis B virus (HBV) related cirrhosis patients and analyzed specific differences in all dimensions of HRQoL.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> A total of 349 patients met selection criteria were enrolled. The 36-Item Short-Form Health Survey was adopted.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Results showed that the physiological HRQoL of the cirrhotic group was significantly lower than that of the non-cirrhotic group (<jats:italic>P<\/jats:italic> = 0.003), the psychological HRQoL was also lower (<jats:italic>P<\/jats:italic> = 0.006). HRQoL was significantly negatively correlated with liver stiffness (<jats:italic>P<\/jats:italic> = 0.001). We further evaluated the risk factors associated with poor HRQoL in HBV-related cirrhosis patients. Results showed that positive HBV DNA viral load (OR = 6.296, <jats:italic>P<\/jats:italic> = 0.041) and HCC family history (OR = 36.211, <jats:italic>P<\/jats:italic> = 0.001) were independent factors associated with HRQoL in HBV-related cirrhosis. For better risk stratification of patients, multivariable analyses were conducted to explore the independent factors that affected specific physiological and psychological HRQoL. In specific physiological HRQoL, results show that marital status (OR = 9.971, <jats:italic>P<\/jats:italic> = 0.034), positive HBV DNA viral load (OR = 6.202, <jats:italic>P<\/jats:italic> = 0.042) and antiviral drugs (OR = 0.45, <jats:italic>P<\/jats:italic> = 0.031) were independent factors associated with physiological HRQoL in cirrhosis patients. In psychological HRQoL, only HCC family history was independent risk factors associated with psychological HRQoL (OR = 42.684, <jats:italic>P<\/jats:italic> = 0.002).<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> We found that the impaired HRQoL dimensions of HBV related cirrhosis patients differ between the various subpopulations. According to our results, risk stratification, medical decision making and personalizing interventions could be made.<\/jats:p>","DOI":"10.3389\/fpsyg.2021.770415","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T06:16:01Z","timestamp":1641449761000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Risk Factors Associated With Quality of Life in Patients With Hepatitis B Virus Related Cirrhosis"],"prefix":"10.3389","volume":"12","author":[{"given":"Qi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunxiu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaohang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuwen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhua","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s11136-018-1986-1","article-title":"Health-related quality of life (HRQoL) in beta-thalassemia major (beta-TM) patients assessed by 36-item short form health survey (SF-36): a meta-analysis.","volume":"28","author":"Arian","year":"2019","journal-title":"Qua. Life Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.3748\/wjg.v13.i21.3003","article-title":"Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy.","volume":"13","author":"Bao","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"B3","first-page":"938","article-title":"[The guidelines of prevention and treatment for chronic hepatitis B (2019 version)].","volume":"27","year":"2019","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"B4","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1111\/liv.14647","article-title":"Health related quality of life in chronic liver diseases.","volume":"40","author":"Cortesi","year":"2020","journal-title":"Liver Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","article-title":"Clinical practical guidelines: management of alcoholic liver disease.","volume":"57","year":"2012","journal-title":"J. Hepatol."},{"key":"B6","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ejpn.2014.08.002","article-title":"Measuring health-related quality of life.","volume":"118","author":"Guyatt","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"B8","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S1665-2681(19)31618-7","article-title":"Fatigue and depressive symptoms associated with chronic viral hepatitis patients. health-related quality of life (HRQOL).","volume":"9","author":"Karaivazoglou","year":"2010","journal-title":"Ann. Hepatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009.","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1365-2850.2012.01896.x","article-title":"A review of the measurement properties of the 36-item short-form health survey (SF-36) to determine its suitability for use in an alcohol-dependent population.","volume":"20","author":"McPherson","year":"2013","journal-title":"J. Psychiatr. Ment. Health Nurs."},{"key":"B11","first-page":"114","article-title":"A review of psychosocial issues in patients with chronic hepatitis B.","volume":"16","author":"Modabbernia","year":"2013","journal-title":"Arch. Iran. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol. Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.soc.2018.05.008","article-title":"Health-Related Quality of Life: the Impact on Morbidity and Mortality.","volume":"27","author":"Sitlinger","year":"2018","journal-title":"Surg. Oncol. Clin. N. Am."},{"key":"B14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"AASLD guidelines for treatment of chronic hepatitis B.","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-12-101","article-title":"Significant impairment of health-related quality of life in mainland Chinese patients with chronic hepatitis B: a cross-sectional survey with pair-matched healthy controls.","volume":"12","author":"Zhuang","year":"2014","journal-title":"Health Qual. Life Outcomes"}],"container-title":["Frontiers in Psychology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2021.770415\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T06:16:12Z","timestamp":1641449772000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyg.2021.770415\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":15,"alternative-id":["10.3389\/fpsyg.2021.770415"],"URL":"https:\/\/doi.org\/10.3389\/fpsyg.2021.770415","relation":{},"ISSN":["1664-1078"],"issn-type":[{"value":"1664-1078","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]},"article-number":"770415"}}